F. Bozza
Lancet. Infectious Diseases (Print) · 2007–2020
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Whom F. Bozza trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts F. Bozza overall
Papers from F. Bozza's perspective
Ordered by how strongly the researchers F. Bozza trusts endorse each paper. Same corpus, a different order for every researcher.
- Serial evaluation of the SOFA score to predict outcome in critically ill patients. (Journal of the American Medical Association (JAMA))
- Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (Critical Care Medicine)
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference (Intensive Care Medicine)
- Multiplexed particle-based flow cytometric assays. (JIM - Journal of Immunological Methods)
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study (The Lancet)
- APACHE II: A severity of disease classification system
- The enigma of sepsis. (Journal of Clinical Investigation)
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia (Journal of Thrombosis and Haemostasis)
- D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19 (Journal of Thrombosis and Haemostasis)
- Platelets and the immune continuum (Nature reviews. Immunology)
Their papers
- A minimal common outcome measure set for COVID-19 clinical research (2020) — 1,467 citations
- Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19 (2020) — 618 citations
- Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis (2007) — 738 citations